Director, Global Regulatory Affairs & Clinical Safety, Merck Research Laboratories (MRL)
Case Study: Bouncing Back Strong – Building the Merck Global Regulatory Affairs and Clinical Safety Business Continuity Plan
In June 2017, Merck experienced a cybersecurity incident that identified the need to bolster preparedness for business disruptions. From the fall of 2017 through the present, the Global Regulatory Affairs and Clinical Safety (GRACS) organization prepared its first ever business continuity plan (BCP), including table top exercises and training. This was a massive undertaking for an organization of such breadth (regulatory science, clinical safety, labeling, licensing, operations, etc.) and large size (2,200 employees globally), starting from scratch, and an illuminating experience regarding the risk susceptibility of its systems and processes. GRACS is in a much better place today with a completed BCP across the entire organization and connections with ongoing business continuity, risk management, and resiliency efforts across the company.
FORTUNE 500 TRACK